Paper26323558
MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2.
Chen X and 8 others. Int J Oncol, 2015. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2. Papers, record 26323558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26323558
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Glioma | Major topic |
| Proto-Oncogene Proteins c-bcl-2 | Major topic |
| Antineoplastic Agents | |
| Blotting, Western | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cisplatin | |
| Humans | |
| MicroRNAs | |
| Neoplasm Invasiveness | |
| Reverse Transcriptase Polymerase Chain Reaction |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39334350 | Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39334350 | PubMed |
| 38693503 | Ethanol responsive lnc171 promotes migration and invasion of HCC cells via mir-873-5p/ZEB1 axis. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38693503 | PubMed |
| 35674307 | The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma. | Curr Pharm Des | 2022 | https://conductscience.org/library/papers/35674307 | PubMed |
| 35185415 | MiRNA-873-5p Acts as a Potential Novel Biomarker and Promotes Cervical Cancer Progression by Regulating ZEB1 via Notch Signaling Pathway. | Dose Response | 2021 | https://conductscience.org/library/papers/35185415 | PubMed |
| 34859007 | Comprehensive Analysis of REST/NRSF Gene in Glioma and Its ceRNA Network Identification. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34859007 | PubMed |
| 34676171 | MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis. | Front Oncol | 2021 | https://conductscience.org/library/papers/34676171 | PubMed |
| 34273059 | Exosomal noncoding RNAs: key players in glioblastoma drug resistance. | Mol Cell Biochem | 2021 | https://conductscience.org/library/papers/34273059 | PubMed |
| 34065991 | Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34065991 | PubMed |
| 33301643 | Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers. | FEBS Open Bio | 2021 | https://conductscience.org/library/papers/33301643 | PubMed |
| 33102581 | Mining miRNAs' Expressions in Glioma Based on GEO Database and Their Effects on Biological Functions. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/33102581 | PubMed |
| 32265714 | The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32265714 | PubMed |
| 32098401 | Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32098401 | PubMed |
| 32047564 | Effects of Galectin-1 on Biological Behavior in Cervical Cancer. | J Cancer | 2020 | https://conductscience.org/library/papers/32047564 | PubMed |
| 32010295 | MicroRNA-873 serves a critical role in human cervical cancer proliferation and metastasis via regulating glioma-associated oncogene homolog 1. | Exp Ther Med | 2020 | https://conductscience.org/library/papers/32010295 | PubMed |
| 31902110 | MiR-873, as a suppressor in cervical cancer, inhibits cells proliferation, invasion and migration via negatively regulating ULBP2. | Genes Genomics | 2020 | https://conductscience.org/library/papers/31902110 | PubMed |
| 31819366 | The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells. | Drug Des Devel Ther | 2019 | https://conductscience.org/library/papers/31819366 | PubMed |
| 31579087 | Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31579087 | PubMed |
| 31289617 | MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4. | Oncotarget | 2019 | https://conductscience.org/library/papers/31289617 | PubMed |
| 30813461 | MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer. | Noncoding RNA | 2019 | https://conductscience.org/library/papers/30813461 | PubMed |
| 30654191 | The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers. | Mol Ther Nucleic Acids | 2019 | https://conductscience.org/library/papers/30654191 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| MIR873 | 100126316 | PubTator's text mining | https://conductscience.org/library/genes/100126316 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26323558
GET https://conductscience.org/api/papers/v1/26323558/cited_by?page=2